Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Aradhana Ghosh"'
Autor:
Eric Severson, B.R. Achyut, Mary Nesline, Sarabjot Pabla, Rebecca A. Previs, Geoffrey Kannan, Anjen Chenn, Shengle Zhang, Roger Klein, Jeffrey Conroy, Mark Sausen, Pratheesh Sathyan, Kamal S. Saini, Aradhana Ghosh, Taylor J. Jensen, Prasanth Reddy, Shakti H. Ramkissoon
Publikováno v:
The Journal of Molecular Diagnostics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55f0f24156440efa6897fd66f85eaa0b
https://doi.org/10.1016/j.jmoldx.2023.03.011
https://doi.org/10.1016/j.jmoldx.2023.03.011
Autor:
Aradhana Ghosh, E. Konguvel
Publikováno v:
2022 International Conference on Computer Communication and Informatics (ICCCI).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9e7e2c423baae33f8a981259947385a
https://doi.org/10.1109/iccci54379.2022.9740885
https://doi.org/10.1109/iccci54379.2022.9740885
Publikováno v:
Journal of Clinical Oncology. 37:e18070-e18070
e18070 Background: Real world data (RWD) is increasingly being used to generate evidence that informs clinical care. Calculating outcomes measures using RWD, such as time-on-treatment (ToT), requires accurate medication start/end dates. Whereas intra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73706214e3ec5790b908cdc82d9dd0b5
https://doi.org/10.1200/jco.2019.37.15_suppl.e18070
https://doi.org/10.1200/jco.2019.37.15_suppl.e18070
Publikováno v:
Journal of Clinical Oncology. 37:e18099-e18099
e18099 Background: Real World Data (RWD) is being used for outcomes research and regulatory submissions. A key variable needed to understand treatment outcomes is Line of Therapy (LoT). However, LoT is generally not captured in RWD sources such as el
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a1fef438c4a607c8dbc468cc1ad1a21
https://doi.org/10.1200/jco.2019.37.15_suppl.e18099
https://doi.org/10.1200/jco.2019.37.15_suppl.e18099
Autor:
Aradhana Ghosh, Bryan Clutz, Ali Zaman, Jonathan Hirsch, Melissa Stahl, Nicole Shelby, Alissa M Winzeler, James L. Chen
Publikováno v:
Journal of Clinical Oncology. 36:e18515-e18515
e18515Background: Many health systems seek the ability to share and learn from real-world evidence, or aggregated cancer patient data, to improve patient outcomes. Although precision medicine initi...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac93de43a34f997c7c0c5443cb6beda3
https://doi.org/10.1200/jco.2018.36.15_suppl.e18515
https://doi.org/10.1200/jco.2018.36.15_suppl.e18515
Autor:
Paul D. Tittel, Ali Zaman, James E. Shima, David Leal, James Lin Chen, Aradhana Ghosh, Jonathan Hirsch, Jonathan C. Trent, Bat-Ami Gordon, Jared Cotta, Michael A. Thompson, Jennifer Godden, Antony Ruggeri, James Leighton Weese, Nadia Z Haque, Spencer C. Hoover, Steven N. Kalkanis
Publikováno v:
Journal of Clinical Oncology. 36:e18763-e18763
e18763Background: The lack of interoperability among different electronic medical record (EMR) systems remains a challenge to fulfilling the promises of precision oncology. Typically, cancer outcom...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c06a5f3c3c0390dd1c2012867b0d7e38
https://doi.org/10.1200/jco.2018.36.15_suppl.e18763
https://doi.org/10.1200/jco.2018.36.15_suppl.e18763
Autor:
Michael A. Thompson, Ali Zaman, Alissa M Winzeler, Jonathan Kern, Aradhana Ghosh, Jonathan Hirsch, Jennifer Godden, James Leighton Weese, Maharaj Singh, Burton Larry Eisenberg, Michael J. Demeure, Nadia Z Haque, Spencer C. Hoover, Steven N. Kalkanis
Publikováno v:
Journal of Clinical Oncology. 36:6539-6539
6539Background: Precision medicine (PM) molecular panel (MP) testing report actionable findings with associated targeted therapies (including immunotherapies). However, these actionable findings “r...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6623baecee9f69ab60373013a678571c
https://doi.org/10.1200/jco.2018.36.15_suppl.6539
https://doi.org/10.1200/jco.2018.36.15_suppl.6539
Autor:
Ginger L. Milne, Xi Kathy Zhou, Anna J. Duffield-Lillico, Jason D. Morrow, Aradhana Ghosh, Jay O. Boyle, Geera S. Butala, Andrew J. Dannenberg, Robert A. Newman, Kotha Subbaramaiah
Publikováno v:
Cancer prevention research (Philadelphia, Pa.). 2(4)
Cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO) play a role in inflammation and carcinogenesis. Biomarkers that reflect tobacco smoke–induced tissue injury are needed. In this study, levels of urinary prostaglandin E metabolite (PGE-M) and leuko
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86cde0a1bb80e3969d87d92f7b24049d
https://pubmed.ncbi.nlm.nih.gov/19336721
https://pubmed.ncbi.nlm.nih.gov/19336721